small molecule

INDOCIN SR

INDOMETHACIN

Loss of exclusivityloss of exclusivity
CompanyZYLA LIFE SCIENCES US INC

Drug detail

Brand nameINDOCIN SR
Active ingredientINDOMETHACIN
Strength75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 1982
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

INDOCIN SR patent cliff — loss of exclusivity — | CliffBio